This integrated single-cell analysis revealed that Runx2 is an important TF in the T-cell exhaustion process, a finding that may help improve the effectiveness of HCC therapies and warrants further exploration in the quest for more comprehensive and impactful treatment options. Here, TF is linked to hepatocellular carcinoma.